Amgen Inc
(HKSE:04332)
HK$
1761
0 (0%)
Market Cap: 1.18 Til
Enterprise Value: 1.58 Til
PE Ratio: 36.22
PB Ratio: 20.20
GF Score: 92/100 Amgen Inc at Wells Fargo Healthcare Conference Transcript
Sep 08, 2022 / 01:45PM GMT
Release Date Price:
HK$1850
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Great. Thank you very much for joining us today. Good morning. My name is Mohit Bansal. I'm one of the biopharma analyst here at Wells Fargo. And I have great pleasure of having Amgen management team here. So with us, we have Peter Griffith from -- CFO of the company; and Dr. Dave Reese, EVP and Head of R&D of the company. Thank you very much for joining us today.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Great to be with you, Mohit. Thank you, and thank you, Wells Fargo.
David M. Reese
Amgen Inc. - EVP of Research & Development
Thanks for having us.
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Thank you. So maybe Peter, I'll just turn it over to you if you want to make a brief statement and then we'll go right into Q&A.
Peter H. Griffith
Amgen Inc. - Executive VP & CFO
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot